GSM5257509|P1|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257510|P2|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257511|P3|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257512|P4|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257513|P5|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257514|P6|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257515|P7|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257516|P8|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257517|P9|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257518|P10|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257519|P11|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257520|P12|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257523|P13|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257527|P14|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257531|P15|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257535|P16|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257537|P17|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257538|P18|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257539|P19|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257540|P20|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257541|P21|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257542|P22|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257543|P23|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257544|P24|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257545|P25|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257546|P26|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257547|P27|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257548|P28|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257549|P29|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257550|P30|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257551|P31|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257552|P32|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257553|P33|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease
GSM5257554|P34|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Responder|Anti-PD-1 ICI therapy|Disease
GSM5257555|P35|N/A|N/A|N/A|N/A|Sarcoma|Other|N/A|N/A|N/A|Non-responder|Anti-PD-1 ICI therapy|Disease